title: Gemcitabine, capecitabine and oxaliplatin in advanced biliary tract carcinoma.
authors.affiliation: Department of Oncology, Herlev Hospital, University of Copenhagen , Denmark.
authors.forename: Finn Ole
authors.initials: FO
authors.lastname: Larsen
authors.forename: Anne Haahr
authors.initials: AH
authors.lastname: Mellergaard
authors.forename: Dan Taksony Solyom
authors.initials: DT
authors.lastname: Hoegdall
authors.forename: Lars Henrik
authors.initials: LH
authors.lastname: Jensen
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001650:Bile Duct Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D000069287:Capecitabine; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D004334:Drug Administration Schedule; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000031:analogs & derivatives; D006801:Humans; D008297:Male; D008875:Middle Aged; D009944:Organoplatinum Compounds / Q000008:administration & dosage; D000077150:Oxaliplatin; D012189:Retrospective Studies; D012720:Severity of Illness Index; D000093542:Gemcitabine
chemical_list: D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D003841:Deoxycytidine; D000069287:Capecitabine; D005472:Fluorouracil; D000093542:Gemcitabine